{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:47:32Z","timestamp":1791856052940,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004625","name":"Universiti Teknologi MARA","doi-asserted-by":"publisher","award":["600-UiTMSEL (PI. 5\/4\/8) (011\/2025)"],"award-info":[{"award-number":["600-UiTMSEL (PI. 5\/4\/8) (011\/2025)"]}],"id":[{"id":"10.13039\/501100004625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","award":["600-RMC\/MOHE HICoE CARE-I 5\/3 (01\/2025)"],"award-info":[{"award-number":["600-RMC\/MOHE HICoE CARE-I 5\/3 (01\/2025)"]}],"id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metabolomics"],"DOI":"10.1007\/s11306-026-02526-1","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:16:57Z","timestamp":1791051417000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic biomarkers and metabolic remodelling in genetically characterised hypertrophic cardiomyopathy: a systematic review"],"prefix":"10.1007","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7816-2783","authenticated-orcid":false,"given":"Ammar Hariz","family":"Ahmad Razmy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4957-5369","authenticated-orcid":false,"given":"Normala","family":"Abd Latip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4502-3559","authenticated-orcid":false,"given":"Sharaniza","family":"Ab-Rahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-4839","authenticated-orcid":false,"given":"Siti Hamimah","family":"Sheikh Abdul Kadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"issue":"2","key":"2526_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10545-017-0127-2","volume":"41","author":"FJ Alharbi","year":"2018","unstructured":"Alharbi, F. J., Baig, S., Auray-Blais, C., Boutin, M., Ward, D. G., Wheeldon, N., Steed, R., Dawson, C., Geberhiwot, T., & Hughes, D. A. (2018). Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) fabry disease. Journal of Inherited Metabolic Disease, 41(2), 239\u2013247. https:\/\/doi.org\/10.1007\/s10545-017-0127-2","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"35","key":"2526_CR2","doi-asserted-by":"publisher","first-page":"E8143","DOI":"10.1073\/pnas.1809540115","volume":"115","author":"RL Anderson","year":"2018","unstructured":"Anderson, R. L., Trivedi, D. V., Sarkar, S. S., Henze, M., Ma, W., Gong, H., Rogers, C. S., Gorham, J. M., Wong, F. L., Morck, M. M., Seidman, J. G., Ruppel, K. M., Irving, T. C., Cooke, R., Green, E. M., & Spudich, J. A. (2018). Deciphering the super relaxed state of human \u03b2-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers. Proceedings of the National Academy of Sciences, 115(35), E8143\u2013E8152. https:\/\/doi.org\/10.1073\/pnas.1809540115","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"2526_CR3","unstructured":"Basit H, Alahmadi MH, Sharma S. Hypertrophic Cardiomyopathy. [Updated 2024 Jun 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430788\/"},{"issue":"4","key":"2526_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown, D. A., Perry, J. B., Allen, M. E., Sabbah, H. N., Stauffer, B. L., Shaikh, S. R., Cleland, J. G. F., Colucci, W. S., Butler, J., & Voors, A. A. (2017). Mitochondrial function as a therapeutic target in heart failure. Nature Reviews Cardiology, 14(4), 238\u2013250. https:\/\/doi.org\/10.1038\/nrcardio.2016.203","journal-title":"Nature Reviews Cardiology"},{"issue":"3","key":"2526_CR5","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamacardio.2018.4847","volume":"4","author":"CJ Coats","year":"2019","unstructured":"Coats, C. J., Pavlou, M., Watkinson, O. T., Protonotarios, A., Moss, L., Hyland, R., Rantell, K., Pantazis, A. A., Tome, M., McKenna, W. J., Frenneaux, M. P., Omar, R., & Elliott, P. M. (2019). Effect of trimetazidine dihydrochloride therapy on exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy: A randomized clinical trial. JAMA Cardiology, 4(3), 230\u2013235. https:\/\/doi.org\/10.1001\/jamacardio.2018.4847","journal-title":"JAMA Cardiology"},{"key":"2526_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.mam.2018.08.003","volume":"63","author":"F Cuello","year":"2018","unstructured":"Cuello, F., Wittig, I., Lorenz, K., & Eaton, P. (2018). Oxidation of cardiac myofilament proteins: Priming for dysfunction? Molecular Aspects of Medicine, 63, 47\u201358. https:\/\/doi.org\/10.1016\/j.mam.2018.08.003","journal-title":"Molecular Aspects of Medicine"},{"issue":"2","key":"2526_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","volume":"9","author":"N Frey","year":"2011","unstructured":"Frey, N., Luedde, M., & Katus, H. A. (2011). Mechanisms of disease: Hypertrophic cardiomyopathy. Nature Reviews Cardiology, 9(2), 91\u2013100. https:\/\/doi.org\/10.1038\/nrcardio.2011.159","journal-title":"Nature Reviews Cardiology"},{"issue":"2 Suppl.","key":"2526_CR8","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.amjmed.2023.04.019","volume":"137","author":"SJ Greene","year":"2024","unstructured":"Greene, S. J., Butler, J., & Kosiborod, M. N. (2024). Clinical trials of sodium-glucose co-transporter-2 inhibitors for treatment of heart failure. The American Journal of Medicine, 137(2 Suppl.), S25\u2013S34. https:\/\/doi.org\/10.1016\/j.amjmed.2023.04.019","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"2526_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/cvr\/cvv025","volume":"105","author":"CY Ho","year":"2015","unstructured":"Ho, C. Y., Charron, P., Richard, P., Girolami, F., Van Spaendonck-Zwarts, K. Y., & Pinto, Y. (2015). Genetic advances in sarcomeric cardiomyopathies: State of the art. Cardiovascular Research, 105(4), 397\u2013408. https:\/\/doi.org\/10.1093\/cvr\/cvv025","journal-title":"Cardiovascular Research"},{"key":"2526_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/eschf\/xvag024","author":"T Ikoma","year":"2026","unstructured":"Ikoma, T., Akita, K., Ohno, K., Satoh, T., Sato, R., Islam, A., Islam, M. M., Omagari, R., Komatsu, K., Unno, K., Iguchi, K., Suwa, K., Sakamoto, A., Kahyo, T., Takamisawa, I., Takayama, M., Iwakura, T., Takanashi, S., Saitsu, H., & Maekawa, Y. (2026). Myocardial testosterone glucuronide and disease phenotypes in hypertrophic cardiomyopathy. ESC Heart Failure. https:\/\/doi.org\/10.1093\/eschf\/xvag024","journal-title":"ESC Heart Failure"},{"issue":"6","key":"2526_CR12","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1007\/s12265-023-10398-2","volume":"16","author":"M Jansen","year":"2023","unstructured":"Jansen, M., Schmidt, A. F., Jans, J. J. M., Christiaans, I., van der Crabben, S. N., Hoedemaekers, Y. M., Dooijes, D., Jongbloed, J. D. H., Boven, L. G., Lekanne Deprez, R. H., Wilde, A. A. M., van der Velden, J., de Boer, R. A., van Tintelen, J. P., Asselbergs, F. W., & Baas, A. F. (2023). Circulating acylcarnitines associated with hypertrophic cardiomyopathy severity: An exploratory cross-sectional study in MYBPC3 founder variant carriers. Journal of Cardiovascular Translational Research, 16(6), 1267\u20131275. https:\/\/doi.org\/10.1007\/s12265-023-10398-2","journal-title":"Journal of Cardiovascular Translational Research"},{"key":"2526_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24044031","author":"M Jansen","year":"2023","unstructured":"Jansen, M., Schuldt, M., van Driel, B. O., Schmidt, A. F., Christiaans, I., van der Crabben, S. N., Hoedemaekers, Y. M., Dooijes, D., Jongbloed, J. D. H., Boven, L. G., Deprez, R. H. L., Wilde, A. A. M., Jans, J. J. M., van der Velden, J., de Boer, R. A., van Tintelen, J. P., Asselbergs, F. W., & Baas, A. F. (2023). Untargeted Metabolomics Identifies potential hypertrophic cardiomyopathy biomarkers in carriers of MYBPC3 founder variants. International Journal of Molecular Sciences. https:\/\/doi.org\/10.3390\/ijms24044031","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"2526_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134184","volume":"10","author":"B J\u00f8rgenrud","year":"2015","unstructured":"J\u00f8rgenrud, B., Jalanko, M., Heli\u00f6, T., J\u00e4\u00e4skel\u00e4inen, P., Laine, M., Hilvo, M., Nieminen, M. S., Laakso, M., Hy\u00f6tyl\u00e4inen, T., Ore\u0161i\u010d, M., & Kuusisto, J. (2015). The metabolome in finnish carriers of the MYBPC3-Q1061X mutation for hypertrophic cardiomyopathy. PloS One, 10(8), Article e0134184. https:\/\/doi.org\/10.1371\/journal.pone.0134184","journal-title":"PloS One"},{"issue":"11","key":"2526_CR14","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.jacc.2012.12.024","volume":"61","author":"TD Karamitsos","year":"2013","unstructured":"Karamitsos, T. D., Dass, S., Suttie, J., Sever, E., Birks, J., Holloway, C. J., Robson, M. D., Jerosch-Herold, M., Watkins, H., & Neubauer, S. (2013). Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 61(11), 1169\u20131176. https:\/\/doi.org\/10.1016\/j.jacc.2012.12.024","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"2526_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s44348-025-00050-9","volume":"33","author":"KA Kim","year":"2025","unstructured":"Kim, K. A., & Jung, M. H. (2025). Current and emerging medical and surgical therapy in hypertrophic cardiomyopathy. Journal of Cardiovascular Imaging, 33(1), 13. https:\/\/doi.org\/10.1186\/s44348-025-00050-9","journal-title":"Journal of Cardiovascular Imaging"},{"issue":"3","key":"2526_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/biomedicines13030591","volume":"13","author":"TV Kirichenko","year":"2025","unstructured":"Kirichenko, T. V., Zhivodernikov, I. V., Kozlova, M. A., Markin, A. M., Sinyov, V. V., & Markina, Y. V. (2025). Hypertrophic cardiomyopathy through the lens of mitochondria. Biomedicines, 13(3), 591. https:\/\/doi.org\/10.3390\/biomedicines13030591","journal-title":"Biomedicines"},{"key":"2526_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.cca.2021.05.034","volume":"520","author":"W Liu","year":"2021","unstructured":"Liu, W., Wei, Z., Zhang, Y., Liu, Y., Bai, R., Ma, C., Yang, J., & Sun, D. (2021). Identification of three novel pathogenic mutations in sarcomere genes associated with familial hypertrophic cardiomyopathy based on multi-omics study. Clinica Chimica Acta, 520, 43\u201352. https:\/\/doi.org\/10.1016\/j.cca.2021.05.034","journal-title":"Clinica Chimica Acta"},{"issue":"1","key":"2526_CR18","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1002\/cphy.c230011","volume":"14","author":"R Lopez-Schenk","year":"2023","unstructured":"Lopez-Schenk, R., Collins, N. L., Schenk, N. A., & Beard, D. A. (2023). Integrated functions of cardiac energetics, mechanics, and purine nucleotide metabolism. Comprehensive Physiology, 14(1), 5345\u20135369. https:\/\/doi.org\/10.1002\/cphy.c230011","journal-title":"Comprehensive Physiology"},{"issue":"20","key":"2526_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.jacc.2024.07.043","volume":"84","author":"HS Lumish","year":"2024","unstructured":"Lumish, H. S., Sherrid, M. V., Janssen, P. M. L., Ferrari, G., Hasegawa, K., Castillero, E., Adlestein, E., Swistel, D. G., Topkara, V. K., Maurer, M. S., Reilly, M. P., & Shimada, Y. J. (2024). Comprehensive proteomic profiling of human myocardium reveals signaling pathways dysregulated in hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 84(20), 1999\u20132011. https:\/\/doi.org\/10.1016\/j.jacc.2024.07.043","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"2526_CR20","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J., & Adams, S. H. (2014). Branched-chain amino acids in metabolic signalling and insulin resistance. Nature Reviews Endocrinology, 10(12), 723\u2013736. https:\/\/doi.org\/10.1038\/nrendo.2014.171","journal-title":"Nature Reviews Endocrinology"},{"issue":"7","key":"2526_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian, A. J., & Braunwald, E. (2017). Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circulation Research, 121(7), 749\u2013770. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311059","journal-title":"Circulation Research"},{"issue":"9862","key":"2526_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron, B. J., & Maron, M. S. (2013). Hypertrophic cardiomyopathy. Lancet (London, England), 381(9862), 242\u2013255. https:\/\/doi.org\/10.1016\/S0140-6736(12)60397-3","journal-title":"Lancet (London, England)"},{"issue":"4","key":"2526_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.metrad.2025.100173","volume":"3","author":"P Marques-Alves","year":"2025","unstructured":"Marques-Alves, P., Ferreira, M. J., Silva, R., Borges-Rosa, J., Gomes, A., Abrunhosa, A., Castelo-Branco, M., Jaber, W., & Gon\u00e7alves, L. (2025). 2-[18F]FDG PET\/CT identifies metabolic activity linked to myocardial deformation in hypertrophic cardiomyopathy. Meta-Radiology, 3(4), Article 100173.","journal-title":"Meta-Radiology"},{"issue":"1\u20133","key":"2526_CR24","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.forsciint.2011.10.032","volume":"217","author":"M Montisci","year":"2012","unstructured":"Montisci, M., El Mazloum, R., Cecchetto, G., Terranova, C., Ferrara, S. D., Thiene, G., & Basso, C. (2012). Anabolic androgenic steroids abuse and cardiac death in athletes: Morphological and toxicological findings in four fatal cases. Forensic Science International, 217(1\u20133), e13\u2013e18. https:\/\/doi.org\/10.1016\/j.forsciint.2011.10.032","journal-title":"Forensic Science International"},{"issue":"13","key":"2526_CR25","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/eurheartj\/ehad028","volume":"44","author":"EE Nollet","year":"2023","unstructured":"Nollet, E. E., Duursma, I., Rozenbaum, A., Eggelbusch, M., W\u00fcst, R. C. I., Schoonvelde, S. A. C., Michels, M., Jansen, M., van der Wel, N. N., Bedi, K. C., Margulies, K. B., Nirschl, J., Kuster, D. W. D., & van der Velden, J. (2023). Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration. European Heart Journal, 44(13), 1170\u20131185. https:\/\/doi.org\/10.1093\/eurheartj\/ehad028","journal-title":"European Heart Journal"},{"issue":"3","key":"2526_CR26","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCGEN.123.004369","volume":"17","author":"EE Nollet","year":"2024","unstructured":"Nollet, E. E., Schuldt, M., Sequeira, V., Binek, A., Pham, T. V., Schoonvelde, S. A. C., Jansen, M., Schomakers, B. V., van Weeghel, M., Vaz, F. M., Houtkooper, R. H., Van Eyk, J. E., Jimenez, C. R., Michels, M., Bedi, K. C., Margulies, K. B., dos Remedios, C. G., Kuster, D. W. D., & van der Velden, J. (2024). Integrating clinical phenotype with multiomics analyses of human cardiac tissue unveils divergent metabolic remodeling in genotype-positive and genotype-negative patients with hypertrophic cardiomyopathy. Circulation Genomic and Precision Medicine, 17(3), 238\u2013253.","journal-title":"Circulation Genomic and Precision Medicine"},{"issue":"11","key":"2526_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nrcardio.2016.98","volume":"13","author":"JO Ormerod","year":"2016","unstructured":"Ormerod, J. O., Frenneaux, M. P., & Sherrid, M. V. (2016). Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy. Nature Reviews Cardiology, 13(11), 677\u2013687. https:\/\/doi.org\/10.1038\/nrcardio.2016.98","journal-title":"Nature Reviews Cardiology"},{"key":"2526_CR47","doi-asserted-by":"publisher","unstructured":"Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hr\u00f3bjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., ... Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https:\/\/doi.org\/10.1136\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"issue":"5","key":"2526_CR28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1161\/CIRCRESAHA.122.321956","volume":"132","author":"JM Pioner","year":"2023","unstructured":"Pioner, J. M., Vitale, G., Steczina, S., Langione, M., Margara, F., Santini, L., Giardini, F., Lazzeri, E., Piroddi, N., Scellini, B., Palandri, C., Schuldt, M., Spinelli, V., Girolami, F., Mazzarotto, F., van der Velden, J., Cerbai, E., Tesi, C., Olivotto, I., \u2026 Poggesi, C. (2023). Slower calcium handling balances faster cross-bridge cycling in human MYBPC3 HCM. Circulation Research, 132(5), 628\u2013644. https:\/\/doi.org\/10.1161\/CIRCRESAHA.122.321956","journal-title":"Circulation Research"},{"issue":"6","key":"2526_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3390\/medicina55060299","volume":"55","author":"NM Popa-Fotea","year":"2019","unstructured":"Popa-Fotea, N. M., Micheu, M. M., Bataila, V., Scafa-Udriste, A., Dorobantu, L., Scarlatescu, A. I., Zamfir, D., Stoian, M., Onciul, S., & Dorobantu, M. (2019). Exploring the continuum of hypertrophic cardiomyopathy-from DNA to clinical expression. Medicina (Kaunas, Lithuania), 55(6), 299. https:\/\/doi.org\/10.3390\/medicina55060299","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"6","key":"2526_CR30","volume":"15","author":"MJ Previs","year":"2022","unstructured":"Previs, M. J., O\u2019Leary, T. S., Morley, M. P., Palmer, B. M., LeWinter, M., Yob, J. M., Pagani, F. D., Petucci, C., Kim, M. S., Margulies, K. B., Arany, Z., Kelly, D. P., & Day, S. M. (2022). Defects in the proteome and metabolome in human hypertrophic cardiomyopathy. Circulation: Heart failure, 15(6), Article e009521.","journal-title":"Circulation: Heart failure."},{"issue":"21","key":"2526_CR31","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri, S., Kooiker, K. B., Ellenberger, M., Fajardo, G., Zhao, M., Vander Roest, A. S., Woldeyes, R. A., Koyano, T. T., Fong, R., Ma, N., Tian, L., Traber, G. M., Chan, F., Perrino, J., Reddy, S., Chiu, W., Wu, J. C., Woo, J. Y., Ruppel, K. M., \u2026 Bernstein, D. (2021). Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation, 144(21), 1714\u20131731. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053575","journal-title":"Circulation"},{"key":"2526_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/metabo12050437","author":"R Ravi","year":"2022","unstructured":"Ravi, R., Silva, L. F., Vangipurapu, J., Maria, M., Raivo, J., Helisalmi, S., & Laakso, M. (2022). Metabolite signature in the carriers of pathogenic genetic variants for cardiomyopathy: A population-based METSIM study. Metabolites. https:\/\/doi.org\/10.3390\/metabo12050437","journal-title":"Metabolites"},{"key":"2526_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10112950","author":"M Schuldt","year":"2021","unstructured":"Schuldt, M., van Driel, B., Alg\u00fcl, S., Parbhudayal, R. Y., Barge-Schaapveld, D. Q. C. M., G\u00fc\u00e7l\u00fc, A., Jansen, M., Michels, M., Baas, A. F., van de Wiel, M. A., Nieuwdorp, M., Levin, E., Germans, T., Jans, J. J. M., & van der Velden, J. (2021). Distinct metabolomic signatures in preclinical and obstructive hypertrophic cardiomyopathy. Cells. https:\/\/doi.org\/10.3390\/cells10112950","journal-title":"Cells"},{"issue":"12","key":"2526_CR34","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","volume":"65","author":"C Semsarian","year":"2015","unstructured":"Semsarian, C., Ingles, J., Maron, M. S., & Maron, B. J. (2015). New perspectives on the prevalence of hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 65(12), 1249\u20131254. https:\/\/doi.org\/10.1016\/j.jacc.2015.01.019","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"2526_CR35","doi-asserted-by":"publisher","first-page":"27152","DOI":"10.31083\/RCM27152","volume":"26","author":"P Sk\u00f3rka","year":"2025","unstructured":"Sk\u00f3rka, P., Piotrowski, J., Bakinowska, E., Kie\u0142bowski, K., & Pawlik, A. (2025). The role of signalling pathways in myocardial fibrosis in hypertrophic cardiomyopathy. Reviews in Cardiovascular Medicine, 26(2), 27152. https:\/\/doi.org\/10.31083\/RCM27152","journal-title":"Reviews in Cardiovascular Medicine"},{"issue":"3","key":"2526_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W., Fiehn, O., Goodacre, R., Griffin, J. L., Hankemeier, T., Hardy, N., Harnly, J., Higashi, R., Kopka, J., Lane, A. N., Lindon, J. C., Marriott, P., Nicholls, A. W., \u2026 Viant, M. R. (2007). Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics: Official Journal of the Metabolomic Society, 3(3), 211\u2013221. https:\/\/doi.org\/10.1007\/s11306-007-0082-2","journal-title":"Metabolomics: Official Journal of the Metabolomic Society"},{"key":"2526_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","volume":"141","author":"CN Toepfer","year":"2020","unstructured":"Toepfer, C. N., Garfinkel, A. C., Venturini, G., Wakimoto, H., Repetti, G., Alamo, L., Sharma, A., Agarwal, R., Ewoldt, J. F., Cloonan, P., Letendre, J., Lun, M., Olivotto, I., Colan, S., Ashley, E., Jacoby, D., Michels, M., Redwood, C. S., Watkins, H. C., \u2026 Seidman, C. E. (2020). Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy. Circulation, 141, 828\u2013842. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.042339","journal-title":"Circulation"},{"issue":"25","key":"2526_CR38","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.jacc.2016.09.972","volume":"68","author":"JR Ussher","year":"2016","unstructured":"Ussher, J. R., Elmariah, S., Gerszten, R. E., & Dyck, J. R. (2016). The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. Journal of the American College of Cardiology, 68(25), 2850\u20132870. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.972","journal-title":"Journal of the American College of Cardiology"},{"issue":"10","key":"2526_CR39","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1093\/cvr\/cvy147","volume":"114","author":"J Van der Velden","year":"2018","unstructured":"Van der Velden, J., Tocchetti, C. G., Varricchi, G., Bianco, A., Sequeira, V., Hilfiker-Kleiner, D., Hamdani, N., Leite-Moreira, A. F., Mayr, M., Falc\u00e3o-Pires, I., Thum, T., Dawson, D. K., Balligand, J.-L., & Heymans, S. (2018). Metabolic changes in hypertrophic cardiomyopathies: Scientific update from the working group of myocardial function of the European society of cardiology. Cardiovascular Research, 114(10), 1273\u20131280. https:\/\/doi.org\/10.1093\/cvr\/cvy147","journal-title":"Cardiovascular Research"},{"key":"2526_CR40","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.abb.2019.03.006","volume":"665","author":"HM Viola","year":"2019","unstructured":"Viola, H. M., & Hool, L. C. (2019). Impaired calcium handling and mitochondrial metabolic dysfunction as early markers of hypertrophic cardiomyopathy. Archives of Biochemistry and Biophysics, 665, 166\u2013174. https:\/\/doi.org\/10.1016\/j.abb.2019.03.006","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"2526_CR41","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","volume":"12","author":"JM Walejko","year":"2021","unstructured":"Walejko, J. M., Christopher, B. A., Crown, S. B., et al. (2021). Branched-chain \u03b1-ketoacids are preferentially reaminated and activate protein synthesis in the heart. Nature Communications, 12, 1680. https:\/\/doi.org\/10.1038\/s41467-021-21962-2","journal-title":"Nature Communications"},{"issue":"5","key":"2526_CR42","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/s44161-022-00057-1","volume":"1","author":"W Wang","year":"2022","unstructured":"Wang, W., Wang, J., Yao, K., Wang, S., Nie, M., Zhao, Y., Wang, B., Pang, H., Xu, J., Wu, G., Lu, M., Tang, N., Qi, C., Pei, H., Luo, X., Li, D., Yang, T., Sun, Q., Wei, X., \u2026 Hu, Z. (2022). Metabolic characterization of hypertrophic cardiomyopathy in human heart. Nature Cardiovascular Research, 1(5), 445\u2013461. https:\/\/doi.org\/10.1038\/s44161-022-00057-1","journal-title":"Nature Cardiovascular Research"},{"issue":"6","key":"2526_CR43","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","volume":"27","author":"PJ White","year":"2018","unstructured":"White, P. J., McGarrah, R. W., Grimsrud, P. A., Tso, S. C., Yang, W. H., Haldeman, J. M., Grenier-Larouche, T., An, J., Lapworth, A. L., Astapova, I., Hannou, S. A., George, T., Arlotto, M., Olson, L. B., Lai, M., Zhang, G. F., Ilkayeva, O., Herman, M. A., Wynn, R. M., \u2026 Newgard, C. B. (2018). The BCKDH kinase and phosphatase integrate BCAA and lipid metabolism via regulation of ATP-citrate lyase. Cell Metabolism, 27(6), 1281-1293.e7. https:\/\/doi.org\/10.1016\/j.cmet.2018.04.015","journal-title":"Cell Metabolism"},{"key":"2526_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-021-02437-0","author":"NL Wolter","year":"2021","unstructured":"Wolter, N. L., LeClair, M. J., & Chin, M. T. (2021). Plasma metabolomic profiling of hypertrophic cardiomyopathy patients before and after surgical myectomy suggests postoperative improvement in metabolic function. BMC Cardiovascular Disorders. https:\/\/doi.org\/10.1186\/s12872-021-02437-0","journal-title":"BMC Cardiovascular Disorders"},{"key":"2526_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1529921","author":"Y Wu","year":"2025","unstructured":"Wu, Y., Zhang, Y., Zheng, Q., Wang, Q., Fang, X., Zhu, Z., Lu, J., & Sun, D. (2025). Myocardial dysfunction caused by MyBPC3 P459fs mutation in hypertrophic cardiomyopathy: Evidence from multi-omics approaches and super-resolution imaging. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/fcvm.2025.1529921","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"5","key":"2526_CR46","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s12265-025-10652-9","volume":"18","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Liu, X., Zhang, Z., Sun, W., Yue, W., Liu, L., Zhu, Y., Zhang, X., & Wang, H. (2025). The diagnostic significance of circulating eicosanoid in patients with hypertrophic cardiomyopathy. Journal of Cardiovascular Translational Research,18(5), 1243\u20131252. https:\/\/doi.org\/10.1007\/s12265-025-10652-9","journal-title":"Journal of Cardiovascular Translational Research"}],"container-title":["Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11306-026-02526-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11306-026-02526-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:02:15Z","timestamp":1791853335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11306-026-02526-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2526"],"URL":"https:\/\/doi.org\/10.1007\/s11306-026-02526-1","relation":{},"ISSN":["1573-3890"],"issn-type":[{"value":"1573-3890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"29 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"164"}}